A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers.
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Neuroendocrine Tumors
Related studies linked through entity extraction aliases.
Developing a Method Using PET-MR to Improve Staging and Monitoring of Neuroendocrine Tumor
- Status
- UNKNOWN
- Phase
- NA
Applying PET/MR in Neuroendocrine Tumors - Imaging Dynamic Processes in Both Modalities
- Status
- UNKNOWN
- Phase
- NA
Sandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation Optimisation
- Status
- TERMINATED
- Phase
- PHASE4
Octreotide LAR in the Induction of Immunologic Response in NENs Patients
- Status
- COMPLETED
- Phase
- PHASE2
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department
- Status
- RECRUITING
- Phase
- NA
Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors
- Status
- RECRUITING
- Phase
- N/A
Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Image-Enhanced Endoscopy in the Gastrointestinal Tract
- Status
- UNKNOWN
- Phase
- N/A
Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers
- Status
- TERMINATED
- Phase
- NA
Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Resection of Metastatic Pancreatic Neuroendocrine Tumors After Induction System Treatment
- Status
- UNKNOWN
- Phase
- N/A
Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia
- Status
- UNKNOWN
- Phase
- N/A
68Ga-DOTATATE PET/CT in Neuroendocrine Tumor
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Open Label Study to Analyze the Effect of Telotristat Ethyl on Weight Regulation/Gain
- Status
- WITHDRAWN
- Phase
- N/A
Peptide Receptor Radionuclide Therapy in the Treatment of Advanced, Non-resectable and/or Symptomatic Tumors With SSTR Overexpression
- Status
- UNKNOWN
- Phase
- PHASE2
The Registry of Oncology Outcomes Associated with Testing and Treatment
- Status
- COMPLETED
- Phase
- N/A
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging
- Status
- UNKNOWN
- Phase
- N/A
Cryoablation of Bone Metastases From Endocrine Tumors
- Status
- TERMINATED
- Phase
- NA